Mingwei Wang

3.7k citations
139 papers · 2.4k · 3 hit papers · h-index 23

Impact in

Papers in

Mingwei Wang

125 papers receiving 2.4k citations

Mingwei Wang's Hit Papers

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis 2022 · 277 citations
2770+3+6Years since publication50100150200250

Peers

Mingwei Wang
Comparison fields: 5 of 180
  • Infectious Diseases 335
  • Endocrinology, Diabetes and Metabolism 238
  • Biological Psychiatry 34
  • Health 86
  • Molecular Biology 644
Replace Xue Li with:
Xue Li China
Yen‐Chin Liu Taiwan
Hiroshi Akasaka Japan
Li Chen China
Min Xie China
Wen‐Jun Tu China
Tommaso Trenti Italy
Virgínia Junqueira Brazil
Jonathan Kopel United States
Qing Su China
Mingwei Wang relative to Xue Li China Xue Li's profile →
Citations per field
00.5×1.5×2.0×
Xue Li · 1×
Citations per year

Countries citing papers authored by Mingwei Wang

Since Specialization
Citations

This map shows the geographic impact of Mingwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingwei Wang more than expected).

Fields of papers citing papers by Mingwei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingwei Wang. The network helps show where Mingwei Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingwei Wang Line = papers co-authored together Mingwei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
Hit paper breakdown →
2016297
2
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis
Hit paper breakdown →
2022277
3
Anxiety, depression, and stress prevalence among college students during the COVID-19 pandemic: A systematic review and meta-analysis
Hit paper breakdown →
2021182
4 2020115
5 201069
6 199166
7 201160
8 202060
9 202157
10 200348
11 202246
12 201842
13 201042
14 200739
15 200938
16 200635
17 202234
18 202233
19 201028
20 201528

About Mingwei Wang

Mingwei Wang is a scholar working on Molecular Biology, Epidemiology, Oncology, Pathology and Forensic Medicine and Health, Toxicology and Mutagenesis, having authored 139 papers that have together received 2.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), COVID-19 and Mental Health (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Vaccine Coverage and Hesitancy (4 papers), Air Quality and Health Impacts (4 papers), Peptidase Inhibition and Analysis (4 papers), Genetic factors in colorectal cancer (4 papers) and Metal Extraction and Bioleaching (3 papers). The work is most often cited by research in Infectious Diseases (335 citations), Endocrinology, Diabetes and Metabolism (238 citations), Biological Psychiatry (34 citations), Health (86 citations) and Molecular Biology (644 citations). Mingwei Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Mengyun Zhou, Yongran Cheng, Chunyi Wang, Zhanhui Feng, Xingwei Zhang, Jiake Tang, Chen Chen, Wen Wen, Caihong Zhou and Qi Wu. Their work appears in journals such as Journal of Infection, Risk Management and Healthcare Policy, Frontiers in Public Health, BMC Public Health and Environmental Science and Pollution Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact